Hey there, bargain hunter.

There is a moment in every long-running investment thesis when the evidence stops being circumstantial and starts being overwhelming. For Morgan Stanley, that moment arrived this morning.

The firm reported Q2 2026 results that didn’t just beat Wall Street estimates. They made the estimates look like they were built on a different company. Record revenue. Record EPS. Record equities trading. Record wealth management revenue. And then, almost as a footnote, the firm crossed $10 trillion in combined client assets across Wealth and Investment Management — a number that Ted Pick has been building toward for years.

The part that most investors will miss: Pick told analysts this morning that the AI investment cycle is only 10% to 15% complete. His internal research projects data center capital spending reaching $850 billion in 2026, $1.3 trillion in 2027, and $1.5 trillion in 2028. That framing matters because Morgan Stanley sits at the institutional center of every dollar of that capital being raised, traded, and deployed.

The Numbers. All of Them.

• Q2 Revenue: $21.35B vs. $19.64B estimate (+27% year over year)
• EPS: $3.46 vs. $2.94 estimate — up from $2.13 a year ago
• Net Income: $5.58B vs. $3.54B a year ago (+58%)
• ROTCE: 26.6%
• Year-to-Date Revenue: $42B with ROTCE of 27%
• Equities Trading: $6.3B — record, up 69% YoY, roughly $1.9B above estimates
• Investment Banking: $2.44B — up 58%, about $270M above estimates
• Fixed Income: $2.46B — up 13%, roughly in line with estimates
• Institutional Securities Revenue: $11B — record, pre-tax profit of $4.3B
• Wealth Management Revenue: $8.86B — record, up 14%, pre-tax margin 30.5%
• Wealth Management Net New Assets: $148.1B — more than double the $59.2B added a year ago
• Investment Management AUM: $2 trillion — record
• Combined Wealth + Investment Management Assets: $10 trillion milestone reached
• CET1 Ratio: 14.8% — over 300 basis points above regulatory requirement
• Efficiency Ratio: 65% year-to-date
• Quarterly Dividend: $1.15/share — raised by $0.15, 12th consecutive annual increase
• Share Repurchases in Q2: $1.5B
• New Buyback Authorization: Up to $20B beginning Q3 2026
• Full-Year 2026 EPS Consensus: $12.33 (per analyst estimates post-release)
• Stock 52-Week Range: $135.26 to $232.11
• Year-to-Date Gain: More than 24%

Analyst Targets

• Bank of America — Buy | Target: $250 (raised from $225 on July 7, 2026)
• Evercore ISI (Glenn Schorr) — Outperform | Target: $233 (raised from $210 on July 6, 2026)
• Barclays — Overweight | Target: $230 (April 16, 2026)
• Yahoo Finance 1-Year Target Estimate: $217.86 (pre-Q2 release consensus, expect upward revisions)

Most investors still think of Morgan Stanley as a trading firm. That framing is at least five years out of date.

What the firm has built is a two-engine machine. The institutional securities business — equities, fixed income, investment banking — captures fees when capital markets are active. The wealth management business captures recurring asset-based fees that rise with equity markets and compound with every dollar of net new assets added. Right now, both engines are running at full capacity at the same time. That doesn’t happen often. When it does, the earnings look like today’s results.

The equities desk is the story that’s getting the most attention, and it deserves it. Analysts had modeled roughly $4.4 billion. The firm delivered $6.3 billion — up 69% from a year earlier — with particular strength in Asia, driven by client engagement and favorable market conditions. That is not a number that happens by accident. It reflects what Morgan Stanley’s research and distribution capabilities are worth to institutional clients navigating an AI-driven market environment.

But here’s what’s actually more interesting to me over a multi-quarter horizon.

The wealth management side added $148.1 billion in net new assets in a single quarter. More than double what it added in the same period last year. A meaningful portion of that came from IPO-related inflows through the workplace and E*TRADE channels — large late-stage private companies going public and funneling assets into the firm’s ecosystem. That’s not a one-time event. As long as the IPO market stays open and AI-related companies continue to list, that pipeline feeds directly into Morgan Stanley’s wealth funnel.

Pick has said he wants standalone wealth assets to grow from $8 trillion to $10 trillion over time. The combined total just hit $10 trillion. The next milestone is already being set.

What the Capital Return Signal Says

The firm has accreted $18 billion of CET1 capital over the last 10 quarters. The CET1 ratio sits at 14.8% — more than 300 basis points above its regulatory minimum. Management doesn’t need to return capital. They’re choosing to, aggressively.

The $20 billion buyback authorization beginning in Q3 is the clearest signal available that the people running this firm believe the current stock price is a good use of shareholder capital. Add a dividend that has now been raised for 12 consecutive years, currently yielding roughly 1.76%, and the shareholder returns picture is more complete than the trading desk headlines suggest.

What Could Go Wrong

Worth being honest about the risks here, because there are real ones.

Equities trading at $6.3 billion is exceptional. It’s also not the baseline. If institutional activity normalizes — say, if equity market volatility collapses, if the AI capital spending cycle slows, or if geopolitical conditions create a risk-off environment — that number comes down. The consensus Q3 estimate is already a step down to $2.99 EPS on $19.74 billion in revenue. The bar has now been raised considerably by today’s beat, which means any softness in Q3 gets amplified.

Insider activity is also worth noting. Over the last six months, insiders have sold shares 28 times with zero purchases. The co-president alone sold nearly 82,000 shares. That doesn’t invalidate the thesis — executives regularly sell for diversification and liquidity reasons — but it’s a data point that belongs in the picture.

And the stock is not cheap by historical standards. At roughly 20.6 times trailing earnings with shares approaching the 52-week high of $232.11, there is not a wide margin for error if the top line disappoints over the next two quarters.

Bull / Base / Bear

Bull: The AI capital spending cycle sustains through 2027 and 2028 at the pace Pick outlined. IPO markets remain open. Wealth management net new assets hold at or above $100 billion per quarter. Full-year EPS lands well above $12.33. BofA’s $250 target proves conservative.

Base: Institutional activity moderates from Q2’s record pace but stays elevated relative to 2025 levels. Wealth management compounds steadily. Full-year EPS tracks toward $12. The stock holds in the $220 to $250 range as buybacks and dividends provide support. Analysts continue revising targets higher through the year.

Bear: A risk-off event — rate hike, geopolitical escalation, equity market correction — compresses both equities trading and wealth management AUM simultaneously. With insider selling elevated and the stock near 52-week highs, any earnings shortfall in Q3 or Q4 could produce a sharper pullback than the fundamentals alone would suggest.

The Cheap Investor Scorecard

• Revenue Growth (Q2 YoY): +27% — Strong
• EPS Beat vs. Consensus: $3.46 vs. $2.94 — Significant
• ROTCE: 26.6% — High quality
• Wealth Management Net New Assets: $148.1B — Record, 2x prior year
• Combined Client Assets: $10 trillion milestone reached
• Capital Return Conviction: $20B buyback + 12th consecutive dividend increase
• Balance Sheet Cushion: CET1 at 14.8%, 300+ bps above requirement
• Valuation: ~20.6x trailing earnings — elevated, not extreme
• Insider Activity: 28 sales, 0 purchases over last 6 months — worth monitoring
• AI Cycle Exposure: Direct, structural, multi-year — early in the cycle per management

What to Watch From Here

• Q3 Equities Trajectory: Can the firm sustain above $5B in equities revenue, or does Q2 represent a ceiling? The answer shapes the full-year EPS range more than any other variable.
• Wealth NNA Pace: Whether $148B in Q2 is repeatable or IPO-driven. Pick’s long-term wealth asset target of $10 trillion standalone is the metric to track quarter by quarter.
• Buyback Execution: Speed and aggressiveness of the $20B authorization in Q3 will signal management’s real-time read on valuation.
• AI Deal Pipeline: Morgan Stanley’s advisory positioning on major AI-era transactions — including potential late-stage private company IPOs — is a key revenue driver heading into 2027.
• Analyst Revisions: Pre-Q2, the Yahoo Finance 1-year consensus target sat at $217.86. Expect a wave of upward revisions in the days ahead as firms update models to reflect today’s results.
• Geopolitical and Rate Risk: Pick named the return of geopolitics as a defining 2026 theme alongside AI. Either variable moving sharply in the wrong direction is the primary macro risk to monitor.

Bottom Line

The debate about whether Morgan Stanley is a trading company or a wealth compounder was settled this morning — at least for now. It’s both. And in Q2 2026, both sides of the business fired at full strength simultaneously.

Record revenue. Record EPS. Record equities. Record wealth. Ten trillion in combined client assets. A $20 billion buyback. A 12th consecutive dividend raise. And a CEO who told analysts this morning that the AI investment cycle is only 10% to 15% complete.

The honest question is not whether Q2 was exceptional. It was. The question is what the next two quarters look like when the comparison gets harder and the equities desk has a record to defend. If the wealth management flywheel keeps turning — and there’s real structural reason to believe it will — the stock has a credible path toward BofA’s $250 target. If institutional activity softens and the Q3 number disappoints, the current valuation leaves limited cushion.

What’s interesting is that even framed conservatively, this is a firm generating $42 billion in revenue through the first half of 2026 alone — on pace for a full year that would dwarf anything in its history. That’s not a trade. That’s a compounding machine. Whether you buy today or wait for a better entry after Q3 is a risk management decision, not a thesis decision.

The thesis is intact. Stronger than it was yesterday.

– TCI